Further studies would be needed to establish whether disruption of LIN28A can be associated with more significant clinical phenotypes in rare cases, such as growth restriction and impaired insulin sensitivity, as well as ovarian insufficiency, or whether relative expression of LIN28A through copy number changes or through variable gene regulation could influence POI phenotypes. This evidence concerns the gene INS and ovarian dysfunction.